Posterior Lateral Fusion (PLF) With Dynesys

September 28, 2011 updated by: Zimmer Biomet

Clinical Outcomes Following Posterior Lateral Fusion With the Dynesys(R) Spinal System

The primary purpose of this study is to track and document the clinical outcomes of patients with radicular pathology following posterior lateral fusion with the Dynesys Spinal System. Secondary purpose of this study is to assess outcomes with historical controls along a continuum of motion and anatomy sparing procedures.

Study Overview

Status

Completed

Conditions

Detailed Description

This study will help the patient to the extent that it will allow the comparison of this unique treatment to the corpus of literature on radicular pathology, thus focusing a specific treatment for a specific pathology.

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77074
        • Foundation Surgical Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Clinical outcomes following postierior lateral fusion with the Dynesys(R) Spinal System

Description

Inclusion Criteria:

  • Spondylolisthesis of less than Grade II at the index level (degenerative with intact pars)
  • Will receive a decompression for lumbar stenosis
  • Symptoms of leg and/or back pain
  • One pathological level
  • Between the ages of 20 and 80 at the time of surgery
  • Non-responsive to non-surgical treatment for at least six months

Exclusion Criteria:

  • Osteolytic spondylolisthesis
  • Planned complete facetectomy
  • Two or more pathological levels (and as enumerated int he Dynesys Spinal system instructions for use)
  • Use in the cervical spine
  • Active systemic or local infection
  • Extreme obesity as defined by a Body Mass Index (BMI)over 40. BMI calculated using Appendix A, adapted from the National Heart, Lung, and Blood Institute, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
  • Pregnancy
  • Mental illness
  • Severe osteoporosis or osteopenia. The World Health Organization defines osteoporosis as BMD<-2.5t. Professional discretion should be used and if bone quality is in question a DEXA scan is recommended.
  • Sensitivities/allergy to metals, polymers, polyethylene, polycarbonate urethane and polyethylene terephthalate
  • Alcohol or drug abuse
  • Patient unwilling or unable to follow postoperative instructions
  • Soft tissue deficit not allowing sound closure
  • Any medical or physical condition that would preclude the potential benefit of spinal surgery
  • Inadequate pedicles of the lumbar or sacral vertebrae; congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of othe devices;
  • Any medical or mental condition which would exclude the patient at high risk from surgery of the severity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Clinical Outcomes
Time Frame: Pre-op, Surgery, 3 month, 6 month, 12 months and 24 months
Pre-op, Surgery, 3 month, 6 month, 12 months and 24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Surgical Outcomes
Time Frame: Pre-op, Surgery, 3 months, 6 months, 12 months and 24 months
Pre-op, Surgery, 3 months, 6 months, 12 months and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Jozef Murar, M.D., Zimmer Spine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2006

Primary Completion (Actual)

March 1, 2011

Study Completion (Actual)

March 1, 2011

Study Registration Dates

First Submitted

November 13, 2008

First Submitted That Met QC Criteria

November 13, 2008

First Posted (Estimate)

November 14, 2008

Study Record Updates

Last Update Posted (Estimate)

September 29, 2011

Last Update Submitted That Met QC Criteria

September 28, 2011

Last Verified

September 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spondylolisthesis

3
Subscribe